MARKET WIRETradingView • 7h ago
Healthcare Triangle, Inc. (HCTI) Sets 1-for-20 Reverse Split to Aid Nasdaq ComplianceTradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
Why HCTI Stock dropped -18.41% Today — RQD Quant Desk Flash
$5.14 -18.41% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $4.96
Healthcare Triangle Inc. (HCTI) carries a Roarable Rating of E (Strong Sell) with 15/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $5.6M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on HCTI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is HCTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 15/100 at a spot price of $5.14 (-18.41% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #713 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does HCTI compare to CYN and VS in the Technology sector?
▼
Within the Technology sector (EDP Services), HCTI carries a Roarable E (15/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for HCTI?
▼
Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $4.96 (-3.50%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (15/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-12.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-19.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HCTI)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (15/100 Composite)
🔍 WHY HCTI SCORES 15/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+7/20 pts (47% of score)
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 33.6 (NEUTRAL RANGE)
▲ #2 Bullish Driver: Cash Engine Quality+4/20 pts (27% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 8890.6% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$8.64-15.7% Next Q
23
Q2 (-2Q)Grade E$7.28-6% Next Q
20
Q3 (-1Q)Grade E$6.84-24.9% Next Q
18
CurrentGrade E$5.14-12.9% Hist 90D α
15
Trajectory: E (23) → E (15)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a HCTI Turnaround Squeeze
While HCTI currently carries a cautious 15/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Technology with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($12.46) and Max Pain ($5.40) forces dealer call-delta covering toward $3,559.50.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $HCTI• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HCTI Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why HCTI Stock dropped -18.41% Today — RQD Quant Desk Flash
Healthcare Triangle Inc. (HCTI) dropped -18.41% to $5.14, trading at 2% of its 52-week range ($5.14 – $3390). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($5.14 – $3390) with RSI-14 at 33.6 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $5.14 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 8890.6% gross margin and $0 annual free cash flow.
Live HCTI Headlines & Catalysts
MARKET WIREMoomoo • 10h ago
Healthcare Triangle: Expects Reverse Stock Split to Increase Share Price >HCTIMoomoo report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREThe Globe and Mail • 13h ago
Healthcare Triangle Enacts Reverse Split Amid Nasdaq ReviewThe Globe and Mail report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 16h ago
Another AI engagement at Healthcare Triangle could target about $3.31M a year, but it remains unsigned.Stock Titan report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 19h ago
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance PlanTradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 22h ago
More than 310 million people live in Malaysia and Indonesia, the initial focus of an AI brain-health initiative.Stock Titan report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 1d ago
Healthcare Triangle announces 1-for-20 reverse split to regain complianceTradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 12h ago
Healthcare Triangle Identifies ~$45M Business Across Hospital, Government, Enterprise Wellness And Neuroscience Programs In Indonesia; No Agreements Signed YetHealthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a provider of digital transformation, AI and cloud solutions for healthcare and life sciences, today announced an update on its
MARKET WIREYahoo • 7d ago
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast AsiaHealthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced the launch of Neurotechnology AI Devices Sales and Soluti
MARKET WIREYahoo • 11d ago
Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum BuildsHealthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced that its wholly owned, AI-led subsidiary, Purpose Health, Inc., has signed a series of multi-year agreements. Purpose Health has signed a
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HCTI)
- ✓Walkthrough of HCTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HCTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -88.37%📐 HORIZONTAL RANGE
2026-11-02O $6.43H $6.43L $5.14C $5.14VOL 18.9K
RES: $66.64SUP: $-4.91SMA50: $12.46SMA200: $65.60
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
HCTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on HCTI today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for HCTI. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HCTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HCTI)
Technology Rank #713 of 714
⚔️ CYN vs HCTI Full Matrix →
1. Head-to-Head Technology Peer Comparison (HCTI vs. CYN, VS, ARBB, AUUD)
Industry: EDP Services (163 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Healthcare Triangle Inc. (HCTI) ranks #713 by composite RQD confidence (15/100, grade E) and #671 by equity capitalization ($5.6M). Within this direct 5-issuer industry benchmark cohort, HCTI leads on earnings valuation at N/A trailing P/E, while VS leads on capital efficiency and profitability with -17.7% ROIC and 96.0% gross margin. ARBB currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with HCTI at 15/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| HCTI
ACTIVE
Healthcare Triangle Inc. | E | 15/100 | — | 96.0% | -35.0% | -18.41% | $5.6M | Benchmark Subject |
| CYN Cyngn Inc. | E | 24/100 | — | 38.0% | -35.0% | -5.49% | $5.6M | /cyn-vs-hcti → |
| VS Versus Systems Inc. | E | 32/100 | — | 96.0% | -17.7% | -3.21% | $5.3M | /vs-vs-hcti → |
| ARBB ARB IOT Group Limited | D | 47/100 | — | — | — | +6.00% | $6.2M | /arbb-vs-hcti → |
| AUUD Auddia Inc. | E | 33/100 | — | — | -35.0% | -5.23% | $4.9M | /auud-vs-hcti → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001839285In its most recent audited fiscal period (FY2025, filed 2025-12-31), Healthcare Triangle Inc. (HCTI) reported GAAP revenue of $13.9M (+18.8% vs. FY2024 revenue of $11.7M , and -58.2% cumulative change since FY2023) , GAAP net income of -$9.5M, operating cash flow of -$16.5M, and free cash flow of -$16.5M (-1429.0% YoY). On the balance sheet, HCTI closed FY2025 with $22.7M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $13.9M | -$9.5M | -$16.5M | -$16.5M | $22.7M | — |
| FY2024 (FY) | 2024-12-31 | $11.7M | -$6.0M | -$1.1M | -$1.1M | $2.0M | — |
| FY2023 (FY) | 2023-12-31 | $33.2M | -$8.7M | -$2.2M | -$2.2M | — | — |
3. HCTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs HCTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 15/100 at a spot price of $5.14 (-18.41% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #713 in composite RQD confidence.
How does HCTI compare to CYN and VS in the Technology sector?
Within the Technology sector (EDP Services), HCTI carries a Roarable E (15/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for HCTI?
Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is HCTI trading relative to its 50-day, 200-day, and 52-week technical levels?
HCTI last traded at $5.14 (-18.41% on volume of 12,343 shares), positioning the stock -58.75% below its 50-day simple moving average ($12.46) and -92.16% below its 200-day simple moving average ($65.60). Across its 52-week range of $5.14 to $3,390.00, HCTI sits at the 0.0% percentile with a 14-day RSI of 33.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.50 to $5.78).
HCTI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HCTI stock moving today?
Why HCTI Stock dropped -18.41% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 15/100 (E)
✓ STAGE-C NUMBER FIREWALL VERIFIED
HCTI — Healthcare Triangle Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:53:05Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, HCTI scores 15 out of 100 and carries a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars break down as follows:
- Fundamental Cash Engine: 0 / 20. Per the Roarable RQD rating, ROIC is -35% and FCF yield is 0%. This pillar contributes nothing to the score, meaning the business is not currently generating returns on capital or free cash flow.
- Whale 13F Flow: 3 / 20. Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. Its low score indicates limited supportive institutional signal in the source data.
- Insider Conviction: 3 / 20. Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The low score indicates weak insider-conviction signal.
- Macro Regime Fit: 7 / 20. Per the Roarable RQD rating, beta is 1.0 with a sector sensitivity profile. This is the highest-scoring pillar, but it reflects only neutral market sensitivity rather than a positive edge.
- Forensic Balance Sheet: 2 / 20. Per the Roarable RQD rating, Altman Z is 0.2, Piotroski F is 3/9, and Debt/Equity is 0.5. These readings point to elevated balance-sheet and distress risk.
For a prospective investor, the rating translates to a short list of concerns: the business is loss-making at every level of the SEC financials shown, the balance-sheet forensic metrics sit in the distress range, and the signal pillars offer little counterweight. Upside drivers are limited to the price's depressed level and the modest macro-fit score; valuation cannot be anchored to earnings because EPS and P/E are not available in source data. The rating's verdict is that the risk-adjusted profile is poor, and an investor evaluating this name today would be weighing a forensic-risk profile rather than a cash-generating franchise.
Business
Healthcare Triangle Inc. is a NASDAQ-listed issuer in the Technology sector, within the EDP Services industry. Per the profile, the company is categorized under these classifications. The source data does not describe its products, customer base, or revenue model beyond the sector and industry labels.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $13.9M | $-9.8M | $-9.5M | N/A | $-16.5M | $7.6M | N/A |
| FY 2024 | $11.7M | $-4.8M | $-6.0M | N/A | $-1.1M | $0.0M | N/A |
| FY 2023 | $33.2M | $-7.7M | $-8.7M | N/A | $-2.2M | N/A | N/A |
Per the SEC financials, the company reported operating and net losses in each of the three periods shown. Per the market data, operating margin and net margin are each -60%, gross margin is 96%, and ROIC is -35%. Per the Roarable RQD rating, the Altman Z-Score is 0.2 and the Piotroski F-Score is 3/9, and Debt/Equity is 0.5. FY 2025 revenue of $13.9M is above FY 2024 but below FY 2023. Debt is not available in source data for any period.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts section, the dominant story is a 1-for-20 reverse stock split tied to Nasdaq compliance, reported across several outlets. Per the same section, a headline references an AI engagement that could target about $3.31M a year but remains unsigned, and another references an AI brain-health initiative with an initial focus on Malaysia and Indonesia. All items are tagged as market wire with a yellow light. Risk watch items include the Nasdaq compliance review implied by the split headlines and the unsigned status of the AI engagement. Per the butterfly supply-chain graph, the supply chain is recorded as NONE with no butterfly links and no proprietary signals.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with an empty set of butterfly links and no proprietary signals. The source data therefore does not establish upstream or downstream dependencies, sector correlations, or second-order bottlenecks. An investor should not infer such linkages from this dataset.
Open Questions
- What is the company's EPS, P/E, and EV/EBITDA, which are all absent from the source data and would be needed to anchor valuation?
- What is the status and timing of the Nasdaq compliance review and the 1-for-20 reverse split, and how will the split affect the share count?
- Does the company have any debt, and what is its liquidity position, given that debt is unavailable across all periods and cash is reported for only two periods?
- Is the AI engagement described in the news wire signed, and what revenue would it contribute relative to the reported losses?
- What products and customers drive the reported revenue of $13.9M in FY 2025?
HCTI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Healthcare Triangle Inc. (HCTI) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE TradingView • 7h ago
Healthcare Triangle, Inc. (HCTI) Sets 1-for-20 Reverse Split to Aid Nasdaq Compliance TradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Moomoo • 10h ago
Healthcare Triangle: Expects Reverse Stock Split to Increase Share Price >HCTI Moomoo report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE The Globe and Mail • 13h ago
Healthcare Triangle Enacts Reverse Split Amid Nasdaq Review The Globe and Mail report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 16h ago
Another AI engagement at Healthcare Triangle could target about $3.31M a year, but it remains unsigned. Stock Titan report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 19h ago
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan TradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 22h ago
More than 310 million people live in Malaysia and Indonesia, the initial focus of an AI brain-health initiative. Stock Titan report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 1d ago
Healthcare Triangle announces 1-for-20 reverse split to regain compliance TradingView report covering Healthcare Triangle Inc. (HCTI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 12h ago
Healthcare Triangle Identifies ~$45M Business Across Hospital, Government, Enterprise Wellness And Neuroscience Programs In Indonesia; No Agreements Signed Yet Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a provider of digital transformation, AI and cloud solutions for healthcare and life sciences, today announced an update on its
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
HCTI Bull vs. Bear Conversation Board — What's Your Call at $5.14?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HCTI 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $5.54 (-12.1%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is HCTI (E • RQD 15/100) a Buy at $6.30?
Welcome to the HCTI (Healthcare Triangle Inc.) Roar Pit. Current RQD Composite is 15/100 (Roarable Strong Sell — Forensic Risk / Avoid) in EDP Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $5.29 (-16.0%)
Spot @ $6.30 Pump the brakes on HCTI — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on HCTI, but look at what you are paying: current EV/EBITDA multiples with 96.0% gross margins. Unless Healthcare Triangle Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
MI MidwestValue Verified K Arena Trader 🐂 BULLISH
🎯 Target: $7.50 (+19.0%)
Spot @ $6.30 HCTI cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on HCTI, the market is fixating on short-term headline noise in EDP Services and ignoring the balance sheet and cash flow trajectory. At $6.30 (52-wk range $5.14 - $3390.00), any beat on forward guidance forces shorts and underweight funds to chase.